OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 02, 2011
Many factors affect research results.
April 21, 2011
Axcan acquires Mpex Pharmaceuticals; Bend Research receives patent for improving bioavailability of low-solubility drugs; and More.
April 02, 2011
Courts and Congress seek to reshape policies and programs.
The contract-research industry in China is growing in leaps and bounds, and Big Pharma is leading the way.
PhRMA efforts of industry's R&D scientists.
Chemocatalytic and biocatalytic routes play an important role in improving the manufacture of intermediates and active pharmaceutical ingredients.
The complexity of third-party external supply networks requires new ways to manage them.
In any industry, inspections can be a pain, and pharma is no exception.
Companies engaged in global mergers and acquisitions may be hearing from the Department of Justice more often to ensure that corruptive practices are not taking place.
The need for greater process understanding raises the bar for suppliers.